The FDA approved pembrolizumab as adjuvant therapy for adults and children aged 12 years or older with stage IIB or IIC melanoma after complete resection.
Publications
Bilateral Paraneoplastic Orbital Myositis Associated With Malignant Melanoma and Multiple Myeloma
Paraneoplastic extraocular muscle enlargement has been reported in a small number of patients with cancers including breast or lymphoma, usually presenting with bilateral multiple muscle involvement.
Sentinel lymph node biopsy positivity in patients with acral lentiginous and other subtypes of cutaneous melanoma
Researchers examined if acral lentiginous melanoma (ALM), a rare subtype of malignant melanoma typically occurring on the palmar and plantar surfaces, is independently linked with sentinel lymph node (SLN) positivity.
Age-Based Disparities in Metastatic Melanoma Patients Treated in the Immune Checkpoint Inhibitors (ICI) Versus Non-ICI Era: A Population-Based Study
Immune checkpoint inhibitors (ICIs) have revolutionized metastatic melanoma treatment, but our knowledge of ICI activity across age groups is insufficient.